CDK1 and acute myeloid leukemia: Table 4 gives an overview of important regulators of the G2 phase that ends up with CDC25 mediated activation of CDK1/cyclin B; the described abnormalities of G2 regulation in primary human AML cells are summarized in the table [95,127,128,129,134,135,136,137,138,139,140].